Skip to main
GEHC

GEHC Stock Forecast & Price Target

GEHC Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 18%
Buy 29%
Hold 53%
Sell 0%
Strong Sell 0%

Bulls say

GE HealthCare Techs is expected to see a boost in sales with new products and focus on innovation and recurring revenue. Despite facing competition and slow margin expansion, the company's commitment to sustainability and correlation between backlog growth and revenue make it well-positioned for future success. With a diverse portfolio and expansion into new markets, GE HealthCare Techs is a strong contender in the medical technology industry, and their investments in AI and digital solutions can further drive growth and profitability.

Bears say

GE HealthCare Techs is facing strong competition in the medical technology market, as well as macroeconomic challenges and regulatory scrutiny. While their strategic shift towards mobile and cable-free interventional systems has been praised, there is a risk of delays or challenges in new product launches. Revenue growth is highly correlated to backlog and orders, but M&A activity and trade dynamics also present risks. The company's BTB ratio and organ

GEHC has been analyzed by 17 analysts, with a consensus rating of Buy. 18% of analysts recommend a Strong Buy, 29% recommend Buy, 53% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GE HealthCare Technologies Inc (GEHC) Forecast

Analysts have given GEHC a Buy based on their latest research and market trends.

According to 17 analysts, GEHC has a Buy consensus rating as of Jul 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $76.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $76.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GE HealthCare Technologies Inc (GEHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.